Literature DB >> 17581626

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

T B Niewold1, J Hua, T J A Lehman, J B Harley, M K Crow.   

Abstract

Interferon alpha (IFN-alpha) levels are elevated in many patients with systemic lupus erythematosus (SLE); however it is not known whether high serum IFN-alpha activity is a cause or a result of the disease. We studied 266 SLE patients and 405 of their healthy relatives, and frequently found high serum IFN-alpha activity in both patients and healthy relatives as compared to healthy unrelated individuals. High IFN-alpha activity was clustered in specific families in both SLE patients and their healthy first-degree relatives, suggesting a heritable trait. Heritability was also supported by quantitative familial correlation of IFN-alpha activity, concordance in affected sib pairs and frequent transmission of the high IFN-alpha activity trait from parents to offspring. Autoantibodies to RNA-binding proteins and double-stranded DNA were associated with high IFN-alpha activity in SLE patients; however these autoantibodies were very uncommon in healthy family members and did not explain the observed familial correlations. The frequency of high IFN-alpha activity was similar across all studied ethnic backgrounds. These data suggest that high serum IFN-alpha activity is a complex heritable trait, which plays a primary role in SLE pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581626      PMCID: PMC2702174          DOI: 10.1038/sj.gene.6364408

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  31 in total

1.  Global landscape of recent inferred Darwinian selection for Homo sapiens.

Authors:  Eric T Wang; Greg Kodama; Pierre Baldi; Robert K Moyzis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

2.  Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.

Authors:  Ullvi Båve; Gunnel Nordmark; Tanja Lövgren; Johan Rönnelid; Stefan Cajander; Maija-Leena Eloranta; Gunnar V Alm; Lars Rönnblom
Journal:  Arthritis Rheum       Date:  2005-04

3.  Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.

Authors:  Kyriakos A Kirou; Christina Lee; Sandhya George; Kyriakos Louca; Ioannis G Papagiannis; Margaret G E Peterson; Ngoc Ly; Robert N Woodward; Kirk E Fry; Anna Yin-Har Lau; James G Prentice; Jay G Wohlgemuth; Mary K Crow
Journal:  Arthritis Rheum       Date:  2004-12

4.  Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.

Authors:  Snaevar Sigurdsson; Gunnel Nordmark; Harald H H Göring; Katarina Lindroos; Ann-Christin Wiman; Gunnar Sturfelt; Andreas Jönsen; Solbritt Rantapää-Dahlqvist; Bozena Möller; Juha Kere; Sari Koskenmies; Elisabeth Widén; Maija-Leena Eloranta; Heikki Julkunen; Helga Kristjansdottir; Kristjan Steinsson; Gunnar Alm; Lars Rönnblom; Ann-Christine Syvänen
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

5.  Initial sequence of the chimpanzee genome and comparison with the human genome.

Authors: 
Journal:  Nature       Date:  2005-09-01       Impact factor: 49.962

6.  Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta.

Authors:  W J Jabs; C Hennig; R Zawatzky; H Kirchner
Journal:  J Interferon Cytokine Res       Date:  1999-05       Impact factor: 2.607

7.  Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

Authors:  Kyriakos A Kirou; Christina Lee; Sandhya George; Kyriakos Louca; Margaret G E Peterson; Mary K Crow
Journal:  Arthritis Rheum       Date:  2005-05

8.  Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.

Authors:  Sergey V Kozyrev; Susanna Lewén; Prasad M V Linga Reddy; Bernardo Pons-Estel; Torsten Witte; Peter Junker; Helle Laustrup; Carmen Gutiérrez; Ana Suárez; Maria Francisca González-Escribano; Javier Martín; Marta E Alarcón-Riquelme
Journal:  Arthritis Rheum       Date:  2007-04

9.  Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.

Authors:  Robert R Graham; Chieko Kyogoku; Snaevar Sigurdsson; Irina A Vlasova; Leela R L Davies; Emily C Baechler; Robert M Plenge; Thearith Koeuth; Ward A Ortmann; Geoffrey Hom; Jason W Bauer; Clarence Gillett; Noel Burtt; Deborah S Cunninghame Graham; Robert Onofrio; Michelle Petri; Iva Gunnarsson; Elisabet Svenungsson; Lars Rönnblom; Gunnel Nordmark; Peter K Gregersen; Kathy Moser; Patrick M Gaffney; Lindsey A Criswell; Timothy J Vyse; Ann-Christine Syvänen; Paul R Bohjanen; Mark J Daly; Timothy W Behrens; David Altshuler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-05       Impact factor: 11.205

Review 10.  Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.

Authors:  Timothy B Niewold; William I Swedler
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 3.650

View more
  207 in total

1.  Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset.

Authors:  Uma Sriram; Linda Varghese; Heather L Bennett; Neelakshi R Jog; Debra K Shivers; Yue Ning; Edward M Behrens; Roberto Caricchio; Stefania Gallucci
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.

Authors:  Sandra Agik; Beverly S Franek; Akaash A Kumar; Marissa Kumabe; Tammy O Utset; Rachel A Mikolaitis; Meenakshi Jolly; Timothy B Niewold
Journal:  J Rheumatol       Date:  2011-11-01       Impact factor: 4.666

3.  B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.

Authors:  Lauren L Ritterhouse; Sherry R Crowe; Timothy B Niewold; Joan T Merrill; Virginia C Roberts; Amy B Dedeke; Barbara R Neas; Linda F Thompson; Joel M Guthridge; Judith A James
Journal:  Arthritis Rheum       Date:  2011-12

4.  Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.

Authors:  Kichul Ko; Beverly S Franek; Miranda Marion; Kenneth M Kaufman; Carl D Langefeld; John B Harley; Timothy B Niewold
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

5.  Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.

Authors:  Rafah Salloum; Beverly S Franek; Silvia N Kariuki; Lesley Rhee; Rachel A Mikolaitis; Meenakshi Jolly; Tammy O Utset; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2010-02

6.  Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort.

Authors:  Clio P Mavragani; Dan T La; William Stohl; Mary K Crow
Journal:  Arthritis Rheum       Date:  2010-02

7.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

8.  Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

Authors:  Corinna E Weckerle; Beverly S Franek; Jennifer A Kelly; Marissa Kumabe; Rachel A Mikolaitis; Stephanie L Green; Tammy O Utset; Meenakshi Jolly; Judith A James; John B Harley; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2011-04

9.  Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.

Authors:  Sheela Shrestha; Barry Wershil; John F Sarwark; Timothy B Niewold; Teresa Philipp; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2010-09

10.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.